Pervasive Developmental Disorder NOS Terminated Phase 1 Trials for Zinc (DB01593)

Also known as: Pervasive Developmental Disorder / Pervasive Developmental Disorders / Autistic continuum / Pervasive Development Disorders / Atypical autism / Autism spectrum disorder

IndicationStatusPhase
DBCOND0046531 (Pervasive Developmental Disorder NOS)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00325572Evaluation and Treatment of Copper/Zinc Imbalance in Children With AutismTreatment